Fri, Feb 27, 2015, 8:24 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • billyteex1 billyteex1 Jun 2, 2009 3:24 PM Flag

    Dr. Berk


    If that was the case, management would have given the usual high praise and wished him the best. Dr. Berk was paid very well for that position and was not part of any team that put these compounds together. It sounds like your transposing your feeling into this situation.

    The not taking any compound without a partner into ph3, is a necessity for SUPG to not burn through the 90M. Dacogen is in trouble on the sales, once eisia stated no guidance, that's not a good sign. I expect to see SUPG share price fall on uncertainity again. I didn't see any release by eisai on ADOPT trial update and CELG did on vidaza. The survival benefit is starting to catch up on cramping SUPG future revenues. Dr. manuso probably understands this better then any investor.

    The tremdous potentials are still 3-6 years away, they need partners and soon or we may tumble lower. The priority has to be getting a drug like s-110 or sgi-1036 into trials and maybe early with a partner. I think Dr. Berk did a very poor job, I wrote Tim Enns early about this choice. The guy screwed up is my opinion and not disgruntled like some investors are. Google Dr. Gregory Berk and you will have a better idea of his character.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
8.4950.0000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.